Qingdao Gather Great Ocean Algae Industry Group

What Qingdao Gather Great Ocean Algae Industry Group does

Qingdao Gather Great Ocean Algae Industry Group (GGOG, 青岛聚大洋藻业集团有限公司) is a privately-held Chinese marine biotechnology enterprise founded in August 2000 and headquartered in Qingdao West Coast New Area, Shandong Province. The company operates a fully integrated seaweed processing group spanning modern marine fisheries, manufacturing, and services, with a documented 'three-level leap' from industrial-grade to food-grade to biomedical-grade products over its 26-year history. It is the founder-controlled family business led by Chairman Wu Shipeng (吴仕鹏), with family members holding the Vice Chairman and General Manager positions.

The company's core technology is seaweed comprehensive deep-processing and high-value utilization, anchored by what it claims is the world's only facility simultaneously producing all three major seaweed gums (sodium alginate, carrageenan, and agar) in a single plant, certified by the China Algae Industry Association in 2019. Its product portfolio spans six lines: hydrocolloids (sodium alginate, alginic acid, carrageenan, agar) sold to food and pharmaceutical manufacturers; seaweed polysaccharide HPMC pharmaceutical hollow capsules (Patent No. 201410129728.4, co-developed with the Chinese Academy of Sciences); alginate oligosaccharide approved as China's first National New Food Ingredient in February 2026; seaweed food products under the '聚小洋' brand; animal feed; and seaweed fertilizer under the 'Deep Sea Dynamic' (深海动力) brand. The firm operates across 'two parks and two bases' including the Marine Biomedical Science and Technology Park (a provincial key project), the world's first seaweed comprehensive processing industrial park, the Lingshan Bay national marine ranch demonstration zone (21,000 mu), and an Australian overseas base covering 450 acres.

The business model is primarily enterprise B2B with regional and product-based direct sales divisions (international: Asia-Australia-Africa, Europe, Americas; domestic: North China, South China, plus dedicated capsule and agricultural product units). Revenue streams span one-time sales of industrial/food/pharmaceutical-grade ingredients, with planned annual capacity of 800 billion HPMC capsules and 50 tons of alginate oligosaccharide. The company has secured an offtake agreement from Xiuzheng Pharmaceutical for 400 billion capsules annually and signed strategic LOIs with four pharmaceutical/biotech partners at the March 2026 AOS launch. Customers include international food manufacturers (anonymously named), pharmaceutical companies, agricultural distributors, and, since 2026, direct consumers via a WeChat official store. The company holds international certifications including ISO9001, ISO22000, HALAL, KOSHER, BRC, NSF, and US FDA registration, and maintains a 20-year raw material supply partnership with Chilean supplier Alimex.

Name

Qingdao Gather Great Ocean Algae Industry Group

Legal name

青岛聚大洋藻业集团有限公司

Website

https://judayang.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Qingdao Gather Great Ocean Algae Industry Group is a Chinese marine biotech enterprise producing seaweed hydrocolloids, pharmaceutical-grade HPMC capsules, and alginate oligosaccharide (approved 2026), serving global food, pharmaceutical, and agricultural manufacturers via direct B2B sales divisions and an emerging WeChat D2C channel.

Ownership category

akta.pro rank

Product category

Seaweed Hydrocolloid Processing and Marine Biomedicine

NAICS

Seafood Product Preparation and Packaging (31171), Animal Production and Aquaculture (112), Aquaculture (1125)

SIC

Wholesale-Chemicals & Allied Products (5160), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Seaweed Hydrocolloids (Agar, Carrageenan, Alginates) (AFAJAMAD)

akta.pro secondary industries

Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE), Aquaculture Processing & On-Farm Value-Add (primary handling, icing, packing) (AFAEAAAN), Seaweed & Dried Vegetable Snacks Manufacturing (AFAKAIAI), Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)

Keywords

• Seaweed hydrocolloid processing
• Alginate carrageenan agar
• Pharmaceutical empty capsules
• Alginate oligosaccharide ingredients
• Seaweed feed and fertilizer

Headquarters

HQ city

Qingdao

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Hydrocolloid Products (Alginate, Carrageenan, Agar): Core revenue driver. Products sold at industrial grade, food grade, and pharmaceutical grade. Applied in meat, noodles, dairy, beverages, and pharmaceutical manufacturing. Mainstay of the company for 20+ years with established international sales network.
2. Seaweed Polysaccharide Pharmaceutical Hollow Capsules: High-margin pharmaceutical excipient product. Patented HPMC seaweed polysaccharide capsules targeting pharmaceutical manufacturers. Subject to GMP production standards. Expansion underway to 200 production lines with annual capacity target of 800 billion capsules through joint venture Qingdao Shenghai Ocean Technology Co., Ltd.
3. Alginate Oligosaccharide (New Food Ingredient): Newest revenue stream. Approved as National New Food Ingredient by NHCC in February 2026. First-ever domestic production and sales qualification globally. Sold via WeChat store and B2B to functional food, beverage, dairy, and supplement manufacturers. Production capacity 50 tons/year.
4. Seaweed Feed and Seaweed Fertilizer: Animal nutrition and plant nutrition products derived from seaweed processing by-products. Seaweed feed replaces expensive mineral and vitamin feed additives. Seaweed fertilizer (brand: Deep Sea Dynamic) sold to agricultural distributors and farmers.
5. Seaweed Food Products: Consumer-facing seaweed food products including kelp shreds and the new '聚小洋' brand launched in 2024. Sold domestically and internationally.
6. Seaweed Fibers and Medical Devices: Medical masks and protective equipment produced during COVID-19 using proprietary seaweed fiber technology. Also includes potential seaweed fiber applications in medical textiles.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Qingdao Gather Great Ocean Algae Industry Group is a full-chain seaweed processing manufacturer that produces industrial, food, and pharmaceutical-grade seaweed hydrocolloids (sodium alginate, alginic acid, carrageenan, agar), plant-based HPMC seaweed polysaccharide pharmaceutical hollow capsules, alginate oligosaccharide approved as a New Food Ingredient, seaweed food products, seaweed feed additives, and seaweed fertilizer. The company operates integrated upstream marine ranching, midstream processing, and downstream product extension across its Qingdao facilities and Australian overseas base.

Product overview

Qingdao Gather Great Ocean Algae Industry Group (GGOG) is a full-chain seaweed comprehensive processing enterprise offering both industrial and consumer-facing products. The core portfolio is organized around six product lines: (1) Hydrocolloids — alginate, alginic acid, carrageenan, and agar as professional-grade food/pharmaceutical ingredients; (2) Pharmaceutical Excipients — seaweed polysaccharide vacant capsules (HPMC Vacant Capsule I) as a plant-based alternative to gelatin capsules, representing the company's high-end biomedical upgrade; (3) Seaweed Food — consumer products under the '聚小洋' brand including kelp-based foods; (4) Seaweed Feed — natural feed additive for livestock and aquaculture; (5) Seaweed Fertilizer — crop nutrition products under the '深海动力' (Deep Sea Power) brand; and (6) Alginate Oligosaccharide — a high-value biotech ingredient approved as a New Food Ingredient (2026), targeting functional foods, beverages, dairy, and dietary supplements for gut-brain health. The company has achieved a 'three-level leap' from industrial grade to food grade to biomedical grade products.

Differentiator

Problem solved

Functional benefit

Brands

• 深海动力: Seaweed fertilizer brand, Deep Sea Dynamic, popular in the market with four series
• 聚小洋

Products and services

• Sodium Alginate (褐藻酸钠)

Named customers5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Qingdao Huanghai Pharmaceutical Co., Ltd. (青岛黄海制药有限责任公司)minorChannel Partner/ Reseller/ Distributor · 20 March 2026Strategic cooperation partner for alginate oligosaccharide product applications in the pharmaceutical sector. Signed strategic cooperation letter of intent at the National New Food Ingredient Launch Ceremony in March 2026.
• Qingdao Hehai Biotechnology Co., Ltd. (青岛和海生物科技有限公司)minorChannel Partner/ Reseller/ Distributor · 20 March 2026Strategic cooperation partner for marine biotechnology product development using alginate oligosaccharide technology. Signed cooperation letter at the March 2026 launch ceremony.
• Shengyuan Laojutang Biotechnology Co., Ltd. (圣元老君堂生物科技有限公司)minorChannel Partner/ Reseller/ Distributor · 20 March 2026Strategic cooperation partner for alginate oligosaccharide nutritional and health product development. Signed cooperation letter at the March 2026 launch ceremony.
• Modu Healthcare (修正国际集团)minorChannel Partner/ Reseller/ Distributor · 20 March 2026Strategic cooperation partner for alginate oligosaccharide product applications in international healthcare markets. Signed cooperation letter at the March 2026 launch ceremony.
• Shandong Talent Development Group (山东人才发展集团有限公司)minorStrategic or Co-development Partner · 29 June 2024Co-established 'Taishan Senior Manager Research Institute Qingdao Training Center' (泰山高级经理研修院青岛培训中心) at the Marine Biomedical Science and Technology Park. Target audience: government officials, maritime enterprise executives, and technical professionals nationwide. Aims to cultivate high-quality marine management talent and build a talent-technology-industry-capital coordination platform.
• Qingdao Huangfa Group (青岛黄岛发展(集团)有限公司)coreStrategic or Co-development Partner · 18 October 2022Strategic cooperation partner for the Marine Biomedical Science and Technology Park. Huangfa Group co-developed the 'Lingshan Bay Marine Industry Technology Collaborative Innovation Exchange Center' (~4,000 sqm) as a coastal leisure cultural tourism complex. Jointly organized the 'Five Institutes产学研 Strategic Cooperation Signing' event with 5 major research institutes including Ocean University of China, Chinese Academy of Sciences Institute of Oceanology, Yellow Sea Fisheries Research Institute, and others.
• Qingdao Haikong Group - West Coast New Area Haikong Ocean Group (青岛西海岸新区海洋控股集团)coreStrategic or Co-development Partner · 12 March 2021Joint venture Qingdao Shenghai Ocean Technology Co., Ltd. (青岛盛海海洋科技有限公司) established to scale the seaweed polysaccharide pharmaceutical hollow capsule business. Haikong Group provides capital and policy support. The venture is implementing a major expansion to 200 production lines with annual capacity of 800 billion capsules. Phase 1 expansion of 8 production lines operational. New 11,000 sqm GMP capsule workshop completed and operational.
• Qingdao University (青岛大学)minorStrategic or Co-development Partner · 15 January 2021Co-established 'Seaweed Health Product Development and Biomass High-Value Utilization Joint Laboratory' (海藻大健康产品开发及生物质高值化利用联合实验室). Research areas include seaweed application technology development, high-end talent cultivation, and physical agriculture applications in marine strategy. Located at company facilities. Led by professors from Qingdao University's Life Sciences College including 泰山产业领军人才 Sun Haixin.
• Qingdao Marine Biomedical Research Institute (青岛海洋生物医药研究院股份有限公司)coreStrategic or Co-development Partner · 26 December 2020Three-party joint venture Qingdao Dakang Marine Biotechnology Co., Ltd. established to build the 'Qingdao International Marine Oligosaccharide Preparation Center Industrialization Base'. The institute provides core technology from Academician Guan Huashi's team (2009 National Technological Invention Award First Prize). The base aims to develop marine oligosaccharide applications in medicine, food, and medical devices, targeting a marine oligosaccharide industrial cluster of RMB 4 billion annual sales. Project planned over 5 years with RMB 1 billion cumulative investment.
• Alimex (Chile - 智利Alimex公司)coreStrategic or Co-development Partner · 1 January 200520-year cooperation partnership (2005-2025) for seaweed raw material procurement from Chile. Alimex is the largest seaweed raw material export enterprise in Chile and globally. Celebrated 20th anniversary in October 2025 with signing of 'New Twenty-Year Strategic Cooperation Win-Win White Paper' covering sustainable seaweed procurement, new product R&D and market co-development, and joint entry into capital markets. Chairman Wu Shipeng described the relationship as a model of 'liver and gall sharing, hand in hand, struggling and striving, creating first-class together'.
• Xiuzheng Pharmaceutical Group (修正药业集团)coreChannel Partner/ Reseller/ DistributorMajor strategic customer partnership. Signed long-term supply agreement for 400 billion seaweed polysaccharide hollow capsules annually. Partnership driving the 800 billion capsule capacity expansion plan at Qingdao Shenghai joint venture. Xiuzheng Pharma is a leading Chinese pharmaceutical manufacturer, providing guaranteed offtake for the expanded capsule production capacity.
• Chinese Academy of Sciences Institute of Oceanology (中国科学院海洋研究所)coreStrategic or Co-development PartnerLong-term R&D partnership including joint postdoctoral program. Postdoctoral researcher 臧金红 completed her research on 'Kelp Deodorization Key Technology and New Product Development' under the joint program. The institute provides scientific expertise for seaweed processing technology and marine biology research.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cargill: Global agricultural and food ingredients giant with significant hydrocolloid and texturizing ingredients business serving food manufacturers and pharmaceutical customers — competes indirectly via broader ingredient portfolio and customer relationships.
• Kerry Group: Global taste and nutrition ingredients company with food hydrocolloid and functional ingredient portfolio — overlaps with the company in food-grade alginate and carrageenan supply to meat, dairy, and beverage manufacturers.
• Lonza Capsules & Health Ingredients: World's largest capsule manufacturer (including acquired Capsugel business) with extensive HPMC plant-based capsule offering — directly competes with the company's seaweed polysaccharide hollow capsule product for pharmaceutical and nutraceutical excipient customers.
• Tate & Lyle: Global food ingredients company with texturizing agents and hydrocolloid portfolio (alginate, carrageenan, pectin) serving food and beverage manufacturers — competes with the company's hydrocolloid range in meat, dairy, and beverage applications.
• IFF (International Flavors & Fragrances, post-DuPont Nutrition merger): Major food ingredients and pharmaceutical excipients provider with broad hydrocolloid and capsule solutions portfolio — overlaps with the company in food-grade seaweed extracts and HPMC capsule supply to pharmaceutical manufacturers.

Direct peers

• CP Kelco: Global leader in alginate, carrageenan, and other seaweed-derived hydrocolloids (acquired from FMC BioPolymer by J.M. Huber in 2023). Most direct comparable in product portfolio, application breadth, and pharmaceutical/food-grade customer base — operates at much larger global scale.
• Qingdao Seawin Biotech Group: Qingdao-based Chinese seaweed fertilizer and bioactive extract producer specializing in seaweed polysaccharides for agriculture and functional food — regional Chinese competitor in adjacent algae-derived biostimulant and food ingredient categories.
• Shandong Jiejing Group: Leading Chinese seaweed processing enterprise producing alginate, carrageenan, agar, and iodine from kelp — the closest domestic Chinese peer competing in the same hydrocolloid categories, supplying both food and pharmaceutical-grade markets domestically and internationally.

Emerging players

• Qualicaps: Specialty capsule manufacturer with HPMC plant-based capsule range serving pharmaceutical and nutraceutical customers — competes with the company's seaweed polysaccharide capsule offering, particularly in the plant-based excipient segment.

Regional players

• Fujian Yiyuan Industrial: Fujian-based Chinese seaweed processing enterprise producing agar and other seaweed-derived products for food applications — regional Chinese competitor with overlapping hydrocolloid product line but primarily serving domestic and Southeast Asian markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/qingdao-gather-great-ocean-algae-industry-group

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qingdao Gather Great Ocean Algae Industry Group